PKU is a prevalent type of inherited metabolic disease, caused by the defective phenylalanine metabolism. In most PKU cases, mutations in the PAH gene could be found. Dysfunction of this hepatic enzyme will lead to diverse clinical symptoms due to a failure in converting phenylalanine into tyrosine. Here, we report an integration-free human induced pluripotent stem cell line (NJMUi001-A) generated from peripheral blood mononuclear cells of a PKU patient by using Sendai virus. This iPS cell line has characteristics of pluripotent stem cells and can be used as a useful tool for the investigation of this inherited metabolic disease.
Pubmed ID: 29154227 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets IgG H&L
View all literature mentionsThis monoclonal targets FOXA2 antibody [EPR4466]
View all literature mentionsThis polyclonal targets alpha smooth muscle Actin
View all literature mentionsThis polyclonal targets beta III Tubulin
View all literature mentionsThis monoclonal targets TRA-1-81
View all literature mentionsThis monoclonal targets TRA-1-60
View all literature mentionsThis monoclonal targets SSEA4
View all literature mentions